Plasma Concentration of Isoniazid and Single-Nucleotide Polymorphisms of N-Acetyltransferase 2 Predict Risk of Systemic Drug Reactions During Weekly Rifapentine and Isoniazid Therapy for Latent Tuberculosis Infection: A Prospective Observational Cohort Study

2018 ◽  
Author(s):  
Meng-Rui Lee ◽  
Hung-Ling Huang ◽  
Shu-Wen Lin ◽  
Ya-Ting Lin ◽  
So-Yi Chang ◽  
...  



Author(s):  
Allyson G. Costa ◽  
Brenda K. S. Carvalho ◽  
Mariana Araújo-Pereira ◽  
Hiochelson N. S. Ibiapina ◽  
Renata Spener-Gomes ◽  
...  

The IGRA has emerged as a useful tool for identifying persons with LTBI. Although the implementation of IGRAs is of utmost importance, to our knowledge there is scarce information on the identification of logistical and technical challenges for systematic screening for LTBI on a large scale.





Author(s):  
Ya-Yen Yu ◽  
Shih-Ming Tsao ◽  
Wen-Ta Yang ◽  
Wei-Chang Huang ◽  
Ching-Hsiung Lin ◽  
...  

Weekly rifapentine and isoniazid therapy (3HP) is the most frequent treatment for latent tuberculosis infection (LTBI). However, the association between major adverse drug reactions (ADRs) and drug metabolic enzyme single-nucleotide polymorphisms (SNPs) remains unclear. In this study, 377 participants who received the 3HP regimen were recruited and examined for genotyping of CYP5A6, CYP2B6, CYP2C19, CYP2E1, and NAT2 SNPs. In our study, 184 participants (48.4%) developed ADRs. Moreover, CYP2C19 rs4986893 (TT vs. CC+CT, odds ratio [OR] [95% CI]: 2.231 [1.015–4.906]), CYP2E1 rs2070676 (CC vs. CG+GG, OR [95% CI]: 1.563 [1.022–2.389]), and CYP2E1 rs2515641 (CC vs. CT+TT, OR [95% CI]: 1.903 [1.250–2.898]) were associated with ADR development. In conclusion, CYP2C19 and CYP2E1 SNPs may provide useful information regarding ADRs in LTBI patients receiving the 3HP regimen.



2020 ◽  
Author(s):  
Verena Rass ◽  
Ronny Beer ◽  
Alois Josef Schiefecker ◽  
Mario Kofler ◽  
Anna Lindner ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document